Anaconda BioMed is a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke. The Company's product, ANCD Brain®, is a novel device intended to be used to restore blood flow in patients experiencing an acute ischemic stroke due to a large vessel neurovascular occlusion. The Device is indicated for thrombus removal by aspiration in intracranial arteries but it remains compatible and can be used in combination with other interventional devices.
Anaconda Biomed total Funding
Anaconda Biomed latest funding size
Time since last funding
|a year ago|
Anaconda Biomed investors
|Ysios Capital, Omega Funds, Innogest Capital, Banco Sabadell|
Anaconda Biomed has 163 number of Twitter Followers. The number of followers has grown 0.9% month over month and grown 3.5% quarter over quarter